Send feedback

IFNAR2 p.Ser53del

c.158_160del · rs1468003457 · VCV3068469

Likely pathogenic Single submitter
Classification
Likely pathogenic
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
gnomAD v4.1
Rare
very rare (popmax 0.00133%, afr)
Conditions
1
immunodeficiency 45

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · substitutions only
Constraint at this position
ConservationphyloP 5.9GERP 5, phastCons 1

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00133% African / African-American · 1/74,980 alleles
Filtering AF 2.8e-05% ClinGen BA1/BS1 input FAF95, joint · FAF99 1.1e-05%
Overall 0.000373% 6/1,610,594 alleles · very rare exomes 6/1,458,238 · genomes 0/152,356 · joint denominator
Ancestry group Frequency 1 in
Finnishnot grpmax-eligible 0.00312% 32,016
African / African-Americangrpmax 0.00133% 74,980
South Asian 0.0011% 91,010
European (non-Finnish) 0.00017% 588,367

Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
IFNAR2
Protein
p.Ser53del
Coding
c.158_160del
MANE Select
NM_001289125
dbSNP
rs1468003457
Type
Deletion
Location
chr21:33245009 (GRCh38)
Gene constraint
LOEUF 0.761 · pLI 0.01 (gnomAD)
Structure
AlphaFold pLDDT 64.86 · 9 PDB
Residue 53
a β-strand
Full IFNAR2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ifnar2-p-ser53del (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown